Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease
Lieberman, A.N.; Gopinathan, G.; Neophytides, A.; Pasternack, P.
New York State Journal of Medicine 86(12): 655-656
1986
ISSN/ISBN: 0028-7628 PMID: 3468386 Document Number: 274816
Document emailed within 1 workday
Related Documents
Rudakova, A.V.; Yakupov, E.Z. 2014: Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 117-121Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Mark, M.H.; Sage, J.I. 1989: Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease Annals of Clinical and Laboratory Science 19(2): 101-106
Martínez-Lage, J.M.; Marti-Massó, J.F.; Delgado, G.; Carreray, N.; Del Amo, F. 1974: A year of treatment with carbidopa and levodopa in Parkinsonian patients Revista Clinica Espanola 134(6): 535-542
Shoulson, I. 1983: Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia Advances in Neurology 37: 259-266
Hauser, R.A. 2004: Levodopa/carbidopa/entacapone (Stalevo) Neurology 62(1 Suppl 1): S64-S71
Klivényi, P.ét.; Vécsei, L.ás.ó 2014: Clinical studies with levodopa/carbidopa intestinal gel Ideggyogyaszati Szemle 67(1-2): 5-8
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease Australian and New Zealand Journal of Medicine 4(4): 373-378
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Singer, E. 1976: Sociopsychological factors influencing response to levodopa therapy for Parkinson's disease Archives of Physical Medicine and Rehabilitation 57(1): 328-334
Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Botez, M.I.; Barbeau, A. 1975: Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy International Journal of Neurology 10(1-4): 222-232
Slaoui, T.; Mas-Gerdelat, A.; Ory-Magne, F.; Rascol, O.; Brefel-Courbon, C. 2007: Levodopa modifies pain thresholds in Parkinson's disease patients Revue Neurologique (Paris) 163(1): 66-71
Steup, A.; Metzner, J.; Voll, A. 1986: Simple photometric method for the determination of L-dopa and carbidopa in drug preparations Die Pharmazie 41(10): 739